Total Voting Rights

Summary by AI ^BETAClose X

Baronsmead Second Venture Trust PLC has announced its total voting rights as of 30 January 2026. The company currently has 480,040,766 ordinary shares in issue, with 55,219,256 held in treasury, resulting in a total of 424,821,510 voting rights. This figure serves as the denominator for shareholders to determine their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

Baronsmead Second Venture Trust PLC

02 February 2026

2 February 2026

Baronsmead Second Venture Trust (the "Company")

Voting Rights and Capital

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R the Company would like to notify the market of the following:

As at the close of business on 30 January 2026, the Company had 480,040,766 Ordinary shares in issue, of which 55,219,256 were held in Treasury. Therefore, the total voting rights in the Company was 424,821,510.

The above figure (424,821,510) may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact:

Baronsmead VCT Investor Relations

020 7382 0999

baronsmeadvcts@greshamhouse.com

LEI: 2138008D3WUMF6TW8C28

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END